These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2308 related items for PubMed ID: 19161186

  • 1. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [Abstract] [Full Text] [Related]

  • 2. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (<or=3 cm) detection].
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y, Chen CZ, Shen JZ, Li RC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 10; 89(9):592-6. PubMed ID: 19595157
    [Abstract] [Full Text] [Related]

  • 3. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul 10; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 4. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
    Nishie A, Tajima T, Ishigami K, Ushijima Y, Okamoto D, Hirakawa M, Nishihara Y, Taketomi A, Hatakenaka M, Irie H, Yoshimitsu K, Honda H.
    J Magn Reson Imaging; 2010 Feb 10; 31(2):373-82. PubMed ID: 20099351
    [Abstract] [Full Text] [Related]

  • 5. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK, Kim CS, Han YM, Lee YH.
    Clin Radiol; 2011 Jun 10; 66(6):489-96. PubMed ID: 21367403
    [Abstract] [Full Text] [Related]

  • 6. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI.
    Low RN, Gurney J.
    J Magn Reson Imaging; 2007 Apr 10; 25(4):848-58. PubMed ID: 17335018
    [Abstract] [Full Text] [Related]

  • 7. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?
    Zhao XT, Li WX, Chai WM, Chen KM.
    J Dig Dis; 2014 Mar 10; 15(3):137-45. PubMed ID: 24354621
    [Abstract] [Full Text] [Related]

  • 8. Does T2-weighted MR imaging improve preoperative detection of malignant hepatic tumors? Observer performance study in 49 surgically proven cases.
    Kondo H, Kanematsu M, Itoh K, Ito K, Maetani Y, Goshima S, Matsuo M, Matsunaga N, Konishi J, Hoshi H, Moriyama N.
    Magn Reson Imaging; 2005 Jan 10; 23(1):89-95. PubMed ID: 15733793
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec 10; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 10. Additional diffusion-weighted imaging in the detection of new, very small hepatocellular carcinoma lesions after interventional therapy compared with conventional 3 T MRI alone.
    Qu JR, Li HL, Shao NN, Li X, Yan GL, Zhang HK, Luo JP, Zhang SN, Li YL, Liu CC.
    Clin Radiol; 2012 Jul 10; 67(7):669-74. PubMed ID: 22336669
    [Abstract] [Full Text] [Related]

  • 11. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW.
    Acta Radiol; 2012 Oct 01; 53(8):830-8. PubMed ID: 22847903
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 3 T MRI of hepatocellular carcinomas in patients with cirrhosis: does T2-weighted imaging provide added value?
    Guo L, Liang C, Yu T, Wang G, Li N, Sun H, Gao F, Liu C.
    Clin Radiol; 2012 Apr 01; 67(4):319-28. PubMed ID: 22099524
    [Abstract] [Full Text] [Related]

  • 14. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD, Kizziah MK, Rissing MS.
    J Comput Assist Tomogr; 2011 Apr 01; 35(6):711-5. PubMed ID: 22082541
    [Abstract] [Full Text] [Related]

  • 15. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep 01; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 16. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.
    Chung J, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW.
    Magn Reson Imaging; 2011 Nov 01; 29(9):1235-43. PubMed ID: 21907517
    [Abstract] [Full Text] [Related]

  • 17. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov 01; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

  • 18. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    J Magn Reson Imaging; 2008 Apr 01; 27(4):834-9. PubMed ID: 18383261
    [Abstract] [Full Text] [Related]

  • 19. Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients.
    Park MS, Kim S, Patel J, Hajdu CH, Do RK, Mannelli L, Babb JS, Taouli B.
    Hepatology; 2012 Jul 01; 56(1):140-8. PubMed ID: 22370974
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
    Nishie A, Stolpen AH, Obuchi M, Kuehn DM, Dagit A, Andresen K.
    J Magn Reson Imaging; 2008 Sep 01; 28(3):705-13. PubMed ID: 18777555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 116.